Silexion Therapeutics Corp
SLXN· Nasdaq
SLXNSilexion Therapeutics Corp
Filed Nov 12, 2025 · 10-Q · 43 days after period end · 0001178913-25-003753
| Metric | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|
| Net Income | -$3.26M | -$11.86M | -$809.00K |
| EPS Diluted | $2.88 | $274.25 | $0.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Silexion Therapeutics Corp · CIK 2022416 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 12, 2025 · 43 d after period end
